Contents:

Cough, Cold and Allergy (hay Fever) Remedies in Hong Kong, China Euromonitor International April 2009 List of Contents and Tables Executive Summary OTC Healthcare Enjoys Good Growth Pain Relief - the Hottest Topic in 2008 Intense Competition Chemists/pharmacies Remain the Most Popular Choice OTC Healthcare To Continue Growing Key Trends and Developments Blurring Boundaries Between OTC and Cosmetics Products Revival of Traditional Chinese Medicine and Herbal Remedies Tourists Boosting Sales of OTC Products Consumers Have More Confidence To Self-medicate for Minor Ailments Child-specific OTC Healthcare Sales Still Small Market Indicators Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008 Table 2 Life Expectancy at Birth 2003-2008 Market Data Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008 Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008 Table 5 OTC Healthcare Company Shares by Value 2004-2008 Table 6 OTC Healthcare Brand Shares by Value 2005-2008 Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008 Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008 Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013 Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013 Appendix OTC Registration and Classification Vitamins & Dietary Supplements Registration and Classification Self-medication and Preventative Medicine Generics Switches Definitions Summary 1 Research Sources Fei Fah Medibalm (hk) Co Strategic Direction Key Facts Summary 2 Fei Fah Medibalm (HK) Co: Key Facts Company Background Production Competitive Positioning Summary 3 Fei Fah Medibalm (HK) Co: Competitive Position 2007 Fortune Pharmacal Co Ltd Strategic Direction Key Facts Summary 4 Fortune Pharmacal Co Ltd: Key Facts Company Background Prodution Competitive Positioning Summary 5 Fortune Pharmacal Co Ltd: Competitive Position 2007 Hoe Hin Pak Fah Yeow Manufacturing Ltd Strategic Direction Key Facts Summary 6 Hoe Hin Pak Fah Yeow Manufacturing Ltd: Key Facts Summary 7 Hoe Hin Pak Fah Yeow Manufactory Ltd: Operational Indicators Company Background Production Competitive Positioning Summary 8 Hoe Hin Pak Fah Yeow Manufacturing Ltd: Competitive Position 2007 Nin Jiom Medicine Mfy (hong Kong) Ltd Strategic Direction Key Facts Summary 9 Nin Jiom Medicine Mfy (Hong Kong) Ltd: Key Facts Company Background Production Competitive Positioning Summary 10 Nin Jiom Medicine Mfy (Hong Kong) Ltd: Competitive Position 2007 Wai Yuen Tong Medicine Holdings Ltd Strategic Direction Key Facts Summary 11 Wai Yuen Tong Medicine Holding Ltd: Key Facts Summary 12 Wai Yuen Tong Medicine Holding Ltd: Operational Indicators Company Background Production Competitive Positioning Summary 13 Wai Yuen Tong Medicine Holding Ltd: Competitive Position 2007 Headlines Trends Switches Competitive Landscape Prospects Sector Data Table 11 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008 Table 12 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008 Table 13 Sales of Decongestants by Type: Value 2003-2008 Table 14 Sales of Decongestants by Type: % Value Growth 2003-2008 Table 15 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008 Table 16 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008 Table 17 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008 Table 18 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008 Table 19 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008 Table 20 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013 Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013

Summary:

Increased health-conscious due to pandemics During the SARS pandemic in 2003, great efforts were made on the part of the Government and medical authorities to educate the general public on personal hygiene and a healthy lifestyle. Two years later, in 2005, consumer health consciousness was re-awakened by the eruption of avian influenza and the fear of human-tohuman transmission. Medical experts issued warnings that avian influenza could turn into a global pandemic, which could cause millions of death. Hence, health-related information in the form of printed materials and through the media was distributed all over Hong Kong. Consumers acquired ample medical knowledge during this period and became more health-conscious. They became much more concerned about maintaining a healthy lifestyle to help prevent contraction of disease. As a result products within vitamins and dietary supplements were in high demand in 2005.

Companies Mentioned

Companies Mentioned Include: - 3M Hong Kong Ltd - Abbott Laboratories Ltd - Advance Pharmaceutical Co Ltd - AstraZeneca Hong Kong Ltd - Aventis Pharma Ltd - Bayer Healthcare Co Ltd - Blackmores Ltd - Boehringer Ingelheim (Hong Kong) Ltd - Boots Co Plc, The - Bristol-Myers Squibb (HK) Ltd - Cerebos Pacific Pte Ltd - Chattem Inc - Eu Yan Sang (Hong Kong) Ltd - Fortune Pharmacal Co Ltd - GlaxoSmithKline HK Ltd - Haw Par Healthcare Ltd - Hoe Hin Pak Fah Yeow Manufacturing Ltd - ICN Pharmaceutical Inc - Jiangzhong Pharmaceutical Co - Johnson & Johnson HK Ltd - Lofthouse of Fleetwood Ltd - Luxembourg Medicine Co Ltd, The - Mentholatum (Asia Pacific) Ltd - Nin Jiom Medicine Mfy (Hong Kong) Ltd - Novartis Pharmaceuticals (HK) Ltd - Pfizer Corp Hong Kong Ltd - Pharmacia Asia Ltd - Procter & Gamble HK Ltd - Products Co Ltd - Puritan's Pride Inc - Reckitt Benckiser HK Ltd - Ricola AG - Roche Hong Kong Ltd - Schering-Plough Corp - Shigaken Pharmaceutical Ind Co - Takeda Chemical Industries Ltd - UCB Pharma (HK) Ltd - Vita Green Health - Whitehall Laboratories Ltd - Wyeth (HK) Ltd